The Food and Drug Administration on Thursday approved remdesivir, an antiviral drug from Gilead Sciences, as a treatment for coronavirus
In May, the FDA granted the drug emergency use authorization, allowing hospitals and doctors to use the drug on patients hospitalized for the disease even though the drug has not been formally approved. By agency Intravenous drug helped shorten recovery time for some hospital patients from Covid-19 It was one of the drugs used to treat President Donald Trump, who tested positive for the virus earlier this month here
Earlier this year, Dr Anthony Fauci, the country’s leading infectious disease specialist, said the drug would set « a new standard of care » for patients with Covid-19
The drug will be used for patients with Covid-19 requiring hospitalization, said Gilead Remdesivir is now the first and only fully approved treatment in the US for Covid-19, which has infected more than 413 million and killed more a million, according to data compiled by Johns Hopkins University
« Since the start of the COVID-19 pandemic, Gilead has worked tirelessly to help find solutions to this global health crisis, » Gilead CEO Daniel O’Day said in a statement “It is incredible to be able today, less than a year since the first reports of cases of the disease now known as COVID-19, to have a treatment approved by the FDA in the US which is available for all appropriate patients in need «
In August, the company announced that it planned to produce more than 2 million treatments of the drug by the end of the year and expected to be able to manufacture « several million more » by 2021, adding that it had increased the supply of drugs more than fifty times since January Its manufacturing network now includes more than 40 companies in North America, Europe and Asia
Data is a real-time snapshot * Data is delayed by at least 15 minutes Global business and financial news, stock quotes and market data and analysis
Gilead Sciences, Food and Drug Administration, Remdesivir, Antiviral, Coronavirus, Healthcare, Emergency Use Clearance
News from around the world – United States – FDA approves Gilead’s remdesivir as a treatment for coronavirus
